Latest news

Press Release - Stockholm based MedTech Start-up Tada Medical AB receives €1,7 Million from EU program EIC Accelerator

80% of in-hospital patients receive IV therapy, where medication and blood are directly infused …

Press Release - Direct issue of new shares

Tada Medical AB announces the decision to increase the share capital through a directed issue of …

Received the Seal of Excellence!

We received the Seal of Excellence for the EU Horizon 2020 SME Application Phase 2!
Click for more news

Latest blogs

blog/home-infusion-

Home Infusion: Advantages and Disadvantages

In today’s times with rising healthcare costs, ways to reduce costs while maintaining the quality of treatment and care are looked up to. There are multiple health services that can be delivered in …
blog/cancer-600-end

ReLink®: A breakthrough in preventing IV dislodgement in oncology treatment

Intravenous (IV) infusions are used for management of various forms of cancer and are part of surgery, chemotherapy, and radiotherapy protocols. A long- term vascular access device (VAD) is usually …
blog/complications-of-iv

Complications of Intravenous (IV) therapy

Intravenous (IV) therapy is a treatment based on infusing various fluids (e.g. medications or blood products) directly into a vein. Approximately 80% of in-hospital patients receive IV therapy. 1 …
Click for more blog posts